Growth Metrics

Zymeworks (ZYME) EBT Growth (1y) (2022 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.59%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -148.28%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -313.33%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 71.54%
7 Evaxion A 62.56 Bn 62.54 Bn - -79.57%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.15%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 9,460.35%
10 Zymeworks 1.84 Bn 1.47 Bn - -109.36%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -109.36%
Dec 31, 2025 -133.15%
Sep 30, 2025 38.34%
Jun 30, 2025 105.66%
Mar 31, 2025 29.89%
Dec 31, 2024 7.36%
Sep 30, 2024 -7.42%
Jun 30, 2024 24.00%
Mar 31, 2024 -37.52%
Dec 31, 2023 -105.99%
Sep 30, 2023 42.40%
Jun 30, 2023 23.41%
Mar 31, 2023 68.41%
Dec 31, 2022 890.75%
Sep 30, 2022 19.96%